Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M39.9Revenue $M6.2Net Margin (%)-179,395.3Z-Score-7.0
Enterprise Value $M-2.1EPS $0.2Operating Margin %-213,526.7F-Score4
P/E(ttm))0Cash Flow Per Share $-1.4Pre-tax Margin (%)-196,521.3Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-13.5Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-52.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-213.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M65.5ROI % (ttm)-76.6Gross Margin Increase y-yY

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEZSJean-Marie Eveillard 2010-03-31 Sold Out $4.8 - $5.58
($4.98)
$ 0.61-88%Sold Out0
AEZSJean-Marie Eveillard 2009-12-31 Reduce$4.74 - $7.5
($6.12)
$ 0.61-90%Reduce -91.09%124,518
AEZSJean-Marie Eveillard 2009-09-30 Buy 0.02%$5.34 - $16.98
($9.72)
$ 0.61-94%New holding, 1397897 sh.1,397,897
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEZS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JrgenDirector 2014-11-12Buy3,100$0.611.64view
Ernst, JrgenDirector 2014-11-12Buy60,000$0.63.33view
Ernst, JrgenDirector 2014-11-12Buy39,400$0.620view
Ernst, JrgenDirector 2014-11-12Buy7,600$0.611.64view
Ernst, JrgenDirector 2014-11-12Buy14,900$0.611.64view
Egbert, CarolynDirector 2014-11-10Buy5,000$0.595.08view
Egbert, CarolynDirector 2014-11-10Buy9,000$0.595.08view
Egbert, CarolynDirector 2014-11-10Buy30,253$0.586.9view
Egbert, CarolynDirector 2014-11-10Buy9,144$0.578.77view
Egbert, CarolynDirector 2014-11-10Buy12,603$0.578.77view

Press Releases about AEZS :

Quarterly/Annual Reports about AEZS:

    News about AEZS:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    comment on AEZS Oct 26 2011 
    Opportunistic Coat-tailing Jan 05 2010 

    More From Other Websites
    Nasdaq stocks posting largest volume increases Dec 16 2014
    SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Aeterna Zentaris... Dec 16 2014
    INVESTOR ALERT: Class Action Lawsuit Against Aeterna Zentaris Inc. Announced by Law Offices of... Dec 16 2014
    SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Aeterna Zentaris... Dec 11 2014
    INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the... Dec 11 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Dec 09 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in... Dec 05 2014
    December 1, 2014 Aeterna Zentaris and Sinopharm A-Think Sign Master Collaboration Agreement for... Dec 01 2014
    Aeterna Zentaris and Sinopharm A-Think Sign Master Collaboration Agreement for Zoptarelin... Dec 01 2014
    Aeterna Zentaris and Sinopharm A-Think Sign Master Collaboration Agreement for Zoptarelin... Dec 01 2014
    EQUITY ALERT: Rosen Law Firm Reminds Aeterna Zentaris, Inc. Investors of Important Deadline in Class... Nov 28 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Nov 25 2014
    Robbins Arroyo LLP: Aeterna Zentaris Inc. (AEZS) Misled Shareholders According to a Recently Filed... Nov 25 2014
    INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000... Nov 21 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Aeterna... Nov 21 2014
    SHAREHOLDER ALERT: Class Action Lawsuit Against Aeterna Zentaris Inc. Filed By Glancy Binkow &... Nov 21 2014
    November 20, 2014 Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in... Nov 20 2014
    Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer Nov 20 2014
    Aeterna Zentaris Adds Hollings Cancer Center to Multi-National Phase 3 Trial in Endometrial Cancer Nov 20 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Nov 18 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK